KBIO COMPANY Inc. Logo

KBIO COMPANY Inc.

Specializes in the plant-based manufacturing of biologics and therapeutics.

038530 | KO

Overview

Corporate Details

ISIN(s):
KR7038530002
LEI:
Country:
South Korea
Address:
서울특별시 강동구 올림픽로 834 206호(암사동, 한강시티라이프), 강동구

Description

KBio specializes in plant-based manufacturing of biologics. The company utilizes its proprietary RP3 platform, which leverages plants as biofoundries for the efficient and sustainable production of high-quality proteins, therapeutics, and other bioactive compounds. This innovative approach is designed to surpass traditional manufacturing limitations, enabling the rapid development and large-scale production of biomolecules. The company's focus includes developing novel product candidates such as antibody therapies to address public health challenges and areas of high unmet medical need.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
[기재정정]사업보고서 (2024.12)
Korean 2.0 MB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.5 MB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.2 MB
2025-03-26 00:00
정기주주총회결과
Korean 18.7 KB
2025-03-18 00:00
감사보고서제출
Korean 25.8 KB
2025-03-18 00:00
사업보고서 (2024.12)
Korean 486.5 KB
2025-03-11 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.8 KB
2025-03-11 00:00
주주총회소집결의
Korean 7.1 KB
2025-03-11 00:00
주주총회소집공고
Korean 181.2 KB
2025-03-07 00:00
감자결정(종속회사의주요경영사항)
Korean 15.6 KB
2024-12-13 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 1.3 MB
2024-10-18 00:00
기타경영사항(자율공시) (자기사채(제26회차 전환사채) 소각 결정의 건)
Korean 5.0 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 1.4 MB
2024-06-14 00:00
본점소재지변경
Korean 5.0 KB

Automate Your Workflow. Get a real-time feed of all KBIO COMPANY Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KBIO COMPANY Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KBIO COMPANY Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.